Effects of levosimendan on mitochondrial function in patients with septic shock: A randomized trial

Biochimie

Volumn 102, Issue 1, 2014, Pages 166-173

  Torraco, Alessandra ^a   Carrozzo, Rosalba ^a   Piemonte, Fiorella ^a   Pastore, Anna ^a   Tozzi, Giulia ^a   Verrigni, Daniela ^a   Assenza, Marco ^b   Orecchioni, Alessandra ^b   D'Egidio, Annalia ^b   Marraffa, Elisa ^b   Landoni, Giovanni ^c   Bertini, Enrico ^a   Morelli, Andrea ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Glutathione; Levosimendan; Mitochondria; Oxidative stress; Sepsis

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; GLUTATHIONE; LEVOSIMENDAN; NORADRENALIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SIMENDAN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BIOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RESPIRATORY CHAIN; SEPTIC SHOCK; STEADY STATE; VASTUS LATERALIS MUSCLE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEMODYNAMICS; METABOLISM; MIDDLE AGED; MITOCHONDRION; PATHOLOGY; SHOCK, SEPTIC; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ELECTRON TRANSPORT COMPLEX I; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; MITOCHONDRIA; OXIDATIVE STRESS; PYRIDAZINES; REACTIVE OXYGEN SPECIES; SHOCK, SEPTIC; SUPEROXIDE DISMUTASE;

EID: 84901811172     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.03.006     Document Type: Article

References (50)

1. E. Abraham, and M. Singer Mechanisms of sepsis-induced organ dysfunction Crit. Care. Med. 35 2007 2408 2416
2. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N. Engl. J. Med. 348 2003 138 150
3. D. Brealey, M. Brand, I. Hargreaves, S. Heales, J. Land, and R. Smolenski et al. Association between mitochondrial dysfunction and severity and outcome of septic shock Lancet 360 2002 219 223
4. E. Crouser Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome Mitochondrion 4 2004 729 741
5. A. Protti, and M. Singer Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure Crit. Care 10 2006 228
6. M. Singer Mitochondrial function in sepsis: acute phase versus multiple organ failure Crit. Care Med. 35 2007 441 448
7. D.E. Taylor, and C.A. Piantadosi Oxidative metabolism n sepsis and sepsis syndrome J. Crit. Care 10 1995 122 135
8. E. Crimi, V. Sica, A.S. Slutsky, H. Zhang, S. Williams-Ignarro, and R.J. Ignarro et al. Role of oxidative stress in experimental sepsis and multisystem organ dysfunction Free Radic. Res. 40 2006 665 672
9. B. von Dessauer, J. Bongain, V. Molina, J. Quilodràn, R. Castillo, and R. Rodrigo Oxidative stress as a novel target in pediatric sepsis management J. Crit. Care 26 2011 103e1 103e7
10. K. Drosatos, R.S. Khan, C.M. Trent, H. Jiang, N.H. Son, and W.S. Blaner et al. Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice Circ. Heart Fail. 6 2013 550 562
11. J. Piquereau, R. Godin, S. Deschenes, V.L. Bessi, M. Mofarrahi, and S.N. Hussain et al. Protective role of PARK2/Parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction Autophagy 9 2013 11
12. A. Noto, M. Giacomini, A. Palandi, L. Stabile, C. Reali-Forster, and G. Iapichino Levosimendan in septic cardiac failure Intensive Care Med. 31 2005 164 165
13. A. Morelli, S. De Castro, J.L. Teboul, M. Singer, M. Rocco, and G. Conti et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression Intensive Care Med. 31 2005 638 644
14. A. Morelli, J.L. Teboul, S.M. Maggiore, A. Vieillard-Baron, M. Rocco, and G. Conti et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study Crit. Care Med. 34 2006 2287 2293
15. B.P. Powell, and B.L. De Keulenaer Levosimendan in septic shock: a case series Br. J. Anaesth. 99 2007 447 448
16. A. Morelli, A. Donati, C. Ertmer, S. Rehberg, M. Lange, and A. Orecchioni et al. Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study Crit. Care 14 2010 R232
17. Z. Papp, I. Édes, S. Fruhwald, S.G. De Hert, M. Salmenperä, and H. Leppikangas et al. Molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan Int. J. Cardiol. 159 2012 82 87
18. C. Avgeropoulou, I. Andreadou, S. Markantonis-Kyroudis, M. Demopoulou, P. Missovoulos, and A. Androulakis et al. The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine Eur. J. Heart Fail. 7 2005 882 887
19. I. Gecit, S. Kavak, M.B. Yuksel, H. Basel, H. Bektas, and H.A. Gumrukcuoglu et al. Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats Toxicol. Ind. Heath 30 2014 47 51
20. D.M. Kopustinskiene, P. Pollesello, and N.E. Saris Levosimendan is a mitochondrial K(ATP) channel opener Eur. J. Pharmacol. 428 2001 311 314
21. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, R. Jaeschke International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2008 Crit. Care Med. 36 2008 296 327
22. M. Bugiani, F. Invernizzi, S. Alberio, E. Briem, E. Lamantea, and F. Carrara et al. Clinical and molecular findings in children with complex I deficiency Biochim. Biophys. Acta 1659 2004 136 147
23. M.B. Yuksel, S. Kavak, I. Gecit, H. Basel, H.A. Gümrükç üoǧlu, and H. Demir et al. Short-term levosimendan treatment protects rat testes against oxidative stress Braz. J. Med. Biol. Res. 45 2012 716 720
24. R.C. Scarpulla Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator Ann. N.Y. Acad. Sci. 1147 2008 321 334
25. E. Levy, and B.H. Ruebner Hepatic changes produced by a single dose of endotoxin in the germfree mouse. Histochemistry, light microscopy, fluorescence microscopy, and electron microscopy Am. J. Pathol. 52 1968 97 110
26. K. Fredriksson, F. Hammarqvist, K. Strigård, K. Hultenby, O. Ljungqvist, and J. Wernerman et al. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure Am. J. Physiol. Endocrinol. Metab. 291 2006 E1044 E1050 Erratum in: Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1240
27. J.E. Carré, J.C. Orban, L. Re, K. Felsmann, W. Iffert, and M. Bauer et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis Am. J. Respir. Crit. Care. Med. 182 2010 745 751
28. G.C. Brown, A.G. McBride, E.J. Fox, K.S. McNaught, and V. Borutaite Nitric oxide and oxygen metabolism Biochem. Soc. Trans. 25 1997 901 904
29. P.S. Brookes, J.P. Bolaños, and S.J. Heales The assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct FEBS Lett. 446 1999 261 263
30. V.C. Stewart, M.A. Sharpe, J.B. Clark, and S.J. Heales Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain J. Neurochem 75 2000 694 700
31. G. Landoni, G. Biondi-Zoccai, M. Greco, T. Greco, E. Bignami, and A. Morelli et al. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies Crit. Care Med. 40 2012 634 646
32. J.R. Kersten, M.W. Montgomery, P.S. Pagel, and D.C. Warltier Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels Anesth. Analg. 90 2000 5 11
33. A. Lochner, F. Colesky, and S. Genade Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic ionotropic response of the myocardium Cardiovasc. Drugs. Ther. 14 2000 217 281
34. H. Nishida, T. Sato, T. Ogura, and H. Nakaya New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: mitochondrial ion channels and cardioprotection J. Pharmacol. Sci. 109 2009 341 347
35. J. Xie, L. Duan, X. Qian, X. Huang, J. Ding, and G. Hu K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production J. Neurosci. Res. 88 2010 428 437
36. H. Emami, S.S. Talab, B.G. Nezami, A. Elmi, S. Assa, and M.R. Ostovaneh et al. Na(+)-H(+) exchange inhibition attenuates ischemic injury in rat random pattern skin flap: the role of mitochondrial ATP-sensitive potassium channels Eur. J. Pharmacol. 698 2013 330 334
37. J. Hasslacher, K. Bijuklic, C. Bertocchi, J. Kountchev, R. Bellmann, and S. Dunzendorfer et al. Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study Crit. Care 15 2011 R166
38. E. Karakus, Z. Halici, A. Albayrak, Y. Bayir, A. Aydin, and D. Unal et al. Beneficial pharmacological effects of levosimendan on antioxidant status of acute inflammation induced in paw of rat: involvement in inflammatory mediators Basic Clin. Pharmacol. Toxicol. 112 2013 156 163
39. E. Clementi, G.C. Brown, M. Feelisch, and S. Moncada Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione Proc. Natl. Acad. Sci. U. S. A. 95 1998 7631 7636
40. E.R. Taylor, F. Hurrell, R.J. Shannon, T.K. Lin, J. Hirst, and M.P. Murphy Reversible glutathionylation of complex I increases mitochondrial superoxide formation J. Biol. Chem. 278 2003 19603 19610
41. T.R. Hurd, R. Requejo, A. Filipovska, S. Brown, T.A. Prime, and A.J. Robinson et al. Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage J. Biol. Chem. 283 2008 24801 24815
42. T. Wenz, F. Diaz, B.M. Spiegelman, and C.T. Moraes Activation of the PPAR/PGC-1alpha pathway revents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype Cell Metab. 8 2008 249 256
43. x deficiency by activation of the AMPK/PGC-1α axis Cell Metab. 14 2011 80 90
44. A. Golubitzky, P. Dan, S. Weissman, G. Link, J.D. Wikstrom, and A. Saada Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound PLoS One 6 2011
45. E. Masiero, L. Agatea, C. Mammucari, B. Blaauw, E. Loro, M. Komatsu, S. Schiaffino, and M. Sandri et al. Autophagy is required to maintain muscle mass Cell Metab. 10 2009 507 515
46. M. Sandri Autophagy in skeletal muscle FEBS Lett. 584 2010 1411 1416
47. I. Vanhorebeek, J. Gunst, S. Derde, I. Derese, M. Boussemaere, and F. Güiza et al. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients J. Clin. Endocrinol. Metab. 96 2011 633 664
48. D. Martinelli, M. Catteruccia, F. Piemonte, A. Pastore, G. Tozzi, and C. Dionisi-Vici et al. EPI-743 reverses the progression of the pediatric mitochondrial disease genetically defined Leigh syndrome Mol. Genet. Metab. 107 2012 383 388
49. A. Pastore, S. Petrillo, G. Tozzi, R. Carrozzo, D. Martinelli, and C. Dionisi-Vici et al. Glutathione: a redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies Mol. Genet. Metab. 109 2013 208 214
50. L. Van Maldergem, F. Trijbels, S. DiMauro, P.J. Sindelar, O. Musumeci, and A. Janssen et al. Coenzyme Q-responsive Leigh's encephalopathy in two sisters Ann. Neurol. 52 2002 750 754